ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU
zacks.com
Want to monitor VAR.AX?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VAR.AXNo company information available
No data available